Bharat Gakhar from Moglix advocates for a shift to technology-driven, value-based procurement strategies to address supply chain disruptions and unlock efficiency in the pharmaceutical industry.
At the Ahmedabad Pharma Summit 2025, Bharat Gakhar, Director of Moglix, delivered a compelling session focused on the urgent need for transformation in the pharmaceutical supply chain and procurement processes. Recognising the challenges posed by increased demand volatility, fas...
Continue Reading This Article
Enjoy this article as well as all of our content, including reports, news, tips and more.
By registering or signing into your SRM Today account, you agree to SRM Today's Terms of Use and consent to the processing of your personal information as described in our Privacy Policy.
ter time-to-market requirements, and various external disruptions, Gakhar argued that the industry must transition from a traditional cost-centric mindset to a value-centric approach.
Gakhar pointed out that many pharmaceutical companies still rely on manual, fragmented, and reactive procurement systems that are hampering efficiency and leading to missed strategic opportunities. According to him, the future of procurement lies in embracing technology-driven frameworks that enhance demand forecasting accuracy, automate purchase requisition to purchase order workflows, improve vendor management, and maintain clean master data. Such improvements, he suggested, would not only optimise inventory and governance but also provide improved visibility across the supply chain.
Moglix, a global B2B commerce platform operating in over 40 locations including Asia, Europe, and the Middle East, offers precisely these solutions, positioning itself to partner with pharma companies in this journey of digital transformation. The company’s platform incorporates end-to-end procurement and supply chain solutions that streamline operations across diverse industries, including healthcare and pharmaceuticals.
Industry data from Moglix’s digital procurement solutions highlights how integrating spend benchmarking, catalogue-based buying, and ERP system synchronization can significantly enhance transparency, user experience, and decision-making. In particular, the application of data analytics, predictive modelling, blockchain, and IoT sensors within pharma supply chains has shown promise in preemptively addressing disruptions, securing the integrity of medicines, and supporting regulatory compliance.
Gakhar stressed that moving from tactical sourcing to strategic procurement is essential to build agility, ensure compliance, and unlock long-term value in today’s competitive global market. This transformation also calls for an ESG (Environmental, Social, and Governance) and governance-focused mindset, aligning with broader industry trends towards sustainability and responsible sourcing.
The session underscored the importance of adopting a digital-first, data-driven procurement ecosystem that is not only agile but also resilient to supply chain shocks. As supply chains grow increasingly complex and demands more volatile, such proactive strategies supported by platforms like Moglix could become critical enablers of competitive advantage and growth for pharmaceutical companies globally.
Gakhar’s call to reimagine supply chain and procurement ecosystems with advanced technology resonates with wider industry movements aiming to digitize these traditionally siloed functions. With Moglix accelerating supply chain development particularly in emerging markets like the Middle East, the future of pharma procurement looks poised for a shift toward greater efficiency, transparency, and value creation.
Source: Noah Wire Services
